MED dismisses risk-based fee model
Speaking at an MED forum in Auckland yesterday on the discussion document outlining fee and levy options to fund the FMA, MED acting manager, corporate law and governance, Jivan Grewal, said whatever options were adopted, "I don't think this won't have any distortionary impacts."
Grewal said the aim of the discussion document, and the forums, was for the MED to outline its thinking and to listen to the industry for "arguments we haven't thought about."
During the hour long session he outlined the MED thinking on a number of the fee/levy options and responded to questions from the 20-strong audience.
He said the suggestion of a risk-based model to determine how the FMA was financed, with those involved in riskier and more regulatory demanding practices paying a greater share, had been rejected for a number of reasons.
Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.
You will also be able to comment on articles on Good Returns.